Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 20/20 | 0.87 |
| ▸ | ICAM1 | P05362 | 20/20 | 0.87 |
| ▸ | ITGAL | P20701 | 20/20 | 0.87 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546553 | 1.00 | ITGB2 (0.87) | ITGB2ICAM1ITGALCYP2C9 | |
| SCHEMBL22476466 | 0.94 | ITGB2 (0.78) | ITGB2ICAM1ITGALCYP2C9 | |
| SCHEMBL20833713 | 0.94 | ITGB2 (0.87) | ITGB2ICAM1ITGALCYP2C9 | |
| SCHEMBL23422265 | 0.94 | ITGB2 (0.89) | ITGB2ICAM1ITGALCYP2C9 | |
| SCHEMBL29720428 | 0.94 | ITGB2 (0.89) | ITGB2ICAM1ITGALCYP2C9 | |
| SCHEMBL20833718 | 0.94 | ITGB2 (0.89) | ITGB2ICAM1ITGALCYP2C9 | |
| Lifitegrast SCHEMBL31010393 | 0.93 | ITGB2 (1.00) | ITGB2ICAM1ITGALCYP2C9 | |
| Lifitegrast SCHEMBL2632068 | 0.93 | ITGB2 (1.00) | ITGB2ICAM1ITGALCYP2C9 | |
| Lifitegrast SCHEMBL22556043 | 0.93 | ITGB2 (1.00) | ITGB2ICAM1ITGALCYP2C9 | |
| Lifitegrast SCHEMBL29355715 | 0.93 | ITGB2 (1.00) | ITGB2ICAM1ITGALCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3807268-B1 | PROCESS FOR THE PREPARATION OF LIFITEGRAST | OLON SPA (IT) | 2024-01-24 | — | — | EP | disclosed |
| EP-3715345-A2 | PREPARATION OF LFA-1 INHIBITOR AND POLYMORPH THEREOF | Novartis AG (CH) | 2020-09-30 | — | — | EP | disclosed |
| WO-2019053607-A1 | PROCESS FOR PREPARATION OF LIFITEGRAST | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2019-03-21 | — | — | WO | disclosed |